07/16/2025
6:02 PM | BlackRock, Inc. (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
06/18/2025
3:14 PM | Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:15 PM | Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:17 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:19 PM | Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
5:02 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
5:01 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
4:30 PM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/28/2025
5:02 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/06/2025
11:15 PM | Zentalis Pharmaceuticals (Filer)
| Form EFFECT | |
03/17/2025
5:13 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ZNTL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
11:13 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
7:06 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
5:29 PM | EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
5:30 PM | Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
5:31 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
5:32 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
5:33 PM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:37 PM | EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:06 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/03/2025
6:12 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
6:13 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
6:14 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
11:44 AM | Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/31/2025
9:09 AM | VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/29/2025
8:18 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
9:08 AM | Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/08/2025
5:49 PM | Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
12/10/2024
11:42 AM | Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/06/2024
10:44 AM | FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
12/03/2024
6:02 PM | EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:02 PM | Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:44 PM | Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:45 PM | EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:46 PM | Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:46 PM | Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
7:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
1:47 PM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/04/2024
1:16 PM | VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
7:59 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
11:50 AM | STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
This Crypto Is Set to Explode in January (Ad) Free summit reveals where Bitcoin goes after $120k
Don't miss this rare opportunity to learn directly from the experts who are driving this market… Reserve your free spot now. |
10/07/2024
10:37 AM | FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/04/2024
5:01 PM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:02 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:01 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
